vs
Liberty Broadband Corp（LBRDA）与Bio-Techne（TECH）财务数据对比。点击上方公司名可切换其他公司
Bio-Techne的季度营收约是Liberty Broadband Corp的1.2倍（$311.4M vs $261.0M），Liberty Broadband Corp净利率更高（146.7% vs 16.4%，领先130.4%），Liberty Broadband Corp同比增速更快（6.1% vs -1.5%），过去两年Liberty Broadband Corp的营收复合增速更高（4.3% vs 1.3%）
本公司是一家覆盖英、荷、美三地的跨国电信企业，注册地为百慕大，在伦敦、阿姆斯特丹、丹佛设有总部，旗下拥有多家对应司法辖区的运营主体，其中英国主体为公开上市实体，2005年由自由媒体国际业务板块与UnitedGlobalCom合并成立。
Bio-Techne是美国头部生命科学企业，面向科研、诊断及生物工艺市场需求，研发、生产并销售生命科学试剂、仪器及配套服务，产品及解决方案广泛应用于基础研究、体外诊断、生物医药研发生产等场景，可为相关领域从业者提供可靠的专业工具支持。
LBRDA vs TECH — 直观对比
营收规模更大
TECH
是对方的1.2倍
$261.0M
营收增速更快
LBRDA
高出7.6%
-1.5%
净利率更高
LBRDA
高出130.4%
16.4%
两年增速更快
LBRDA
近两年复合增速
1.3%
损益表 — Q2 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $261.0M | $311.4M |
| 净利润 | $383.0M | $51.0M |
| 毛利率 | — | 66.9% |
| 营业利润率 | 15.7% | 24.2% |
| 净利率 | 146.7% | 16.4% |
| 营收同比 | 6.1% | -1.5% |
| 净利润同比 | 96.4% | 126.0% |
| 每股收益（稀释后） | $2.68 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LBRDATECH
| Q1 26 | — | $311.4M | ||
| Q4 25 | — | $295.9M | ||
| Q2 25 | $261.0M | $317.0M | ||
| Q1 25 | $266.0M | $316.2M | ||
| Q4 24 | $263.0M | $297.0M | ||
| Q3 24 | $262.0M | $289.5M | ||
| Q2 24 | $246.0M | $306.1M | ||
| Q1 24 | $245.0M | $303.4M |
净利润LBRDATECH
| Q1 26 | — | $51.0M | ||
| Q4 25 | — | $38.0M | ||
| Q2 25 | $383.0M | $-17.7M | ||
| Q1 25 | $268.0M | $22.6M | ||
| Q4 24 | $291.0M | $34.9M | ||
| Q3 24 | $142.0M | $33.6M | ||
| Q2 24 | $195.0M | $40.6M | ||
| Q1 24 | $241.0M | $49.1M |
毛利率LBRDATECH
| Q1 26 | — | 66.9% | ||
| Q4 25 | — | 64.6% | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% | ||
| Q1 24 | — | 67.4% |
营业利润率LBRDATECH
| Q1 26 | — | 24.2% | ||
| Q4 25 | — | 18.4% | ||
| Q2 25 | 15.7% | -7.5% | ||
| Q1 25 | 16.2% | 12.2% | ||
| Q4 24 | 4.9% | 16.0% | ||
| Q3 24 | 11.5% | 13.8% | ||
| Q2 24 | 8.5% | 15.0% | ||
| Q1 24 | 11.4% | 22.1% |
净利率LBRDATECH
| Q1 26 | — | 16.4% | ||
| Q4 25 | — | 12.8% | ||
| Q2 25 | 146.7% | -5.6% | ||
| Q1 25 | 100.8% | 7.1% | ||
| Q4 24 | 110.6% | 11.7% | ||
| Q3 24 | 54.2% | 11.6% | ||
| Q2 24 | 79.3% | 13.3% | ||
| Q1 24 | 98.4% | 16.2% |
每股收益（稀释后）LBRDATECH
| Q1 26 | — | $0.32 | ||
| Q4 25 | — | $0.24 | ||
| Q2 25 | $2.68 | $-0.11 | ||
| Q1 25 | $1.87 | $0.14 | ||
| Q4 24 | $2.04 | $0.22 | ||
| Q3 24 | $0.99 | $0.21 | ||
| Q2 24 | $1.36 | $0.26 | ||
| Q1 24 | $1.69 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $180.0M | $209.8M |
| 总债务越低越好 | $3.1B | — |
| 股东权益账面价值 | $10.4B | $2.1B |
| 总资产 | $16.6B | $2.6B |
| 负债/权益比越低杠杆越低 | 0.30× | — |
8季度趋势，按日历期对齐
现金及短期投资LBRDATECH
| Q1 26 | — | $209.8M | ||
| Q4 25 | — | $172.9M | ||
| Q2 25 | $180.0M | $162.2M | ||
| Q1 25 | $226.0M | $140.7M | ||
| Q4 24 | $163.0M | $177.5M | ||
| Q3 24 | $168.0M | $187.5M | ||
| Q2 24 | $73.0M | $152.9M | ||
| Q1 24 | $108.0M | $145.3M |
总债务LBRDATECH
| Q1 26 | — | — | ||
| Q4 25 | — | $260.0M | ||
| Q2 25 | $3.1B | $346.0M | ||
| Q1 25 | $3.8B | $330.0M | ||
| Q4 24 | $3.8B | $300.0M | ||
| Q3 24 | $3.7B | $300.0M | ||
| Q2 24 | $3.6B | $319.0M | ||
| Q1 24 | $3.6B | $389.0M |
股东权益LBRDATECH
| Q1 26 | — | $2.1B | ||
| Q4 25 | — | $2.0B | ||
| Q2 25 | $10.4B | $1.9B | ||
| Q1 25 | $10.1B | $2.0B | ||
| Q4 24 | $9.8B | $2.1B | ||
| Q3 24 | $9.5B | $2.1B | ||
| Q2 24 | $9.3B | $2.1B | ||
| Q1 24 | $9.1B | $2.0B |
总资产LBRDATECH
| Q1 26 | — | $2.6B | ||
| Q4 25 | — | $2.5B | ||
| Q2 25 | $16.6B | $2.6B | ||
| Q1 25 | $17.0B | $2.6B | ||
| Q4 24 | $16.7B | $2.7B | ||
| Q3 24 | $16.3B | $2.7B | ||
| Q2 24 | $16.0B | $2.7B | ||
| Q1 24 | $15.7B | $2.7B |
负债/权益比LBRDATECH
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q2 25 | 0.30× | 0.18× | ||
| Q1 25 | 0.38× | 0.16× | ||
| Q4 24 | 0.38× | 0.14× | ||
| Q3 24 | 0.39× | 0.14× | ||
| Q2 24 | 0.39× | 0.15× | ||
| Q1 24 | 0.40× | 0.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $91.0M | — |
| 自由现金流经营现金流 - 资本支出 | $37.0M | — |
| 自由现金流率自由现金流/营收 | 14.2% | — |
| 资本支出强度资本支出/营收 | 20.7% | — |
| 现金转化率经营现金流/净利润 | 0.24× | — |
| 过去12个月自由现金流最近4个季度 | $-49.0M | — |
8季度趋势，按日历期对齐
经营现金流LBRDATECH
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q2 25 | $91.0M | $98.2M | ||
| Q1 25 | $78.0M | $41.1M | ||
| Q4 24 | $1.0M | $84.3M | ||
| Q3 24 | $24.0M | $63.9M | ||
| Q2 24 | $27.0M | $75.5M | ||
| Q1 24 | $52.0M | $81.0M |
自由现金流LBRDATECH
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q2 25 | $37.0M | $93.3M | ||
| Q1 25 | $13.0M | $31.0M | ||
| Q4 24 | $-63.0M | $77.5M | ||
| Q3 24 | $-36.0M | $54.7M | ||
| Q2 24 | $-35.0M | $57.5M | ||
| Q1 24 | $-9.0M | $64.5M |
自由现金流率LBRDATECH
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q2 25 | 14.2% | 29.4% | ||
| Q1 25 | 4.9% | 9.8% | ||
| Q4 24 | -24.0% | 26.1% | ||
| Q3 24 | -13.7% | 18.9% | ||
| Q2 24 | -14.2% | 18.8% | ||
| Q1 24 | -3.7% | 21.3% |
资本支出强度LBRDATECH
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q2 25 | 20.7% | 1.5% | ||
| Q1 25 | 24.4% | 3.2% | ||
| Q4 24 | 24.3% | 2.3% | ||
| Q3 24 | 22.9% | 3.2% | ||
| Q2 24 | 25.2% | 5.9% | ||
| Q1 24 | 24.9% | 5.4% |
现金转化率LBRDATECH
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q2 25 | 0.24× | — | ||
| Q1 25 | 0.29× | 1.82× | ||
| Q4 24 | 0.00× | 2.42× | ||
| Q3 24 | 0.17× | 1.90× | ||
| Q2 24 | 0.14× | 1.86× | ||
| Q1 24 | 0.22× | 1.65× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LBRDA
暂无分部数据
TECH
| Protein Sciences segment revenue | $226.2M | 73% |
| Diagnostics and Spatial Biology segment revenue | $85.6M | 27% |
| Other revenue (1) | $5.4M | 2% |
